- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$405.85 MnMarket Estimate, 2026
$574.28 MnMarket Forecast, 2034
$9229.44 MnCAGR, 2026–2034
41.5%Europe Bioabsorbable Stents Market Size, Growth, Trends & Forecast (2026–2034)
The Europe bioabsorbable stents market size was valued at USD 405.85 million in 2025, reached USD 574.28 million in 2026, and is projected to scale up to USD 9,229.44 million by 2034, registering a robust compound annual growth rate (CAGR) of 41.5% during the forecast period from 2026 to 2034. Driven by the rising incidence of cardiovascular diseases, an expanding aging demographic, and the clinical advantage of completely biodegradable vascular scaffolds that eliminate the need for secondary removal surgeries, the market is expanding rapidly across the region.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 405.85 Million
- 2026 Current Valuation: USD 574.28 Million
- 2034 Forecast Valuation: USD 9,229.44 Million
- Compound Annual Growth Rate (CAGR): 41.5% (2026–2034)
- Prominent Geographic Scope: European nations including the UK, France, Germany, Italy, Spain, and Rest of Europe.
Core Market Drivers
- Cardiovascular Disease Burden: Escalating rates of arterial blockages and heart issues linked to aging populations and obesity.
- Technological Advantages: Positive surgical outcomes and the inherent ability of bioabsorbable stents to dissolve over time, preventing long-term vessel constraint.
Primary Market Restraints & Challenges
- Regulatory & Safety Hurdles: Stringent regulatory frameworks, extensive clinical safety-efficacy validations, and technological complexities.
- High Costs: Substantial financial outlays associated with advanced bioabsorbable materials and clinical procedures.
Europe Bioabsorbable Stents Market Segmentation Highlights
| Segment Category | Key / Covered Sub-Segments |
|---|---|
| By Material | Polymer Stents and Metallic Stents |
| By Absorption Rate | Slow Absorption Rate Stents and High Absorption Rate Stents |
| By Application | Coronary Artery Disease and Peripheral Artery Disease |
| By End User | Hospitals and Cardiac Centers |
| By Country | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe |
Major Industry Players Profiled
Key medical device innovators and market leaders driving the European bioabsorbable stents sector include Abbott Laboratories, Biotronik, Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc., Arterial Remodeling Technologies S.A., Kyoto Medical Planning Co., Ltd., Reva Medical, Inc., Tepha, Inc., SMT, and Xenogenics Corporation.
Europe Bioabsorbable Stents Market Size
The Europe bioabsorbable stents market size was valued at USD 405.85 million in 2025 and is anticipated to reach USD 574.28 million in 2026 from USD 9229.44 million by 2034, growing at a CAGR of 41.5% during the forecast period from 2026 to 2034.
Stents can be generally used as a part of the treatment of blocked arteries. They are small and expandable work tubes that hold arteries open and help treat coronary and peripheral artery diseases. Bioabsorbable stents are called as completely biodegradable stents that totally disappear over time.
A stent is a metallic or a polymer tube inserted into the lumen of any vein or a channel in order to keep the section open. Various stents for different clinical conditions are available in the market. A stent insert is most regularly used for the treatment of cardiovascular variations from the norm, for instance, blocked veins. Stents are implanted in the throat to allow the section of food and beverages in patients to encounter esophageal diseases. They can likewise be utilized as a part of kidneys, stomach and gastrointestinal tract for different purposes. Utilizing of bioabsorbable stents rather than permanent metallic stents takes out the need to experience second surgery to evacuate the metallic stents.
Increment in cardiovascular surgeries is because of the increase in the risk of cardiovascular issues among the general population experiencing weight. According to WHO reports, cardiovascular issues are the primary source of death than some other medical problems, it is normal that by 2030 more than 23 million people suffer from Cardiovascular infections. In this way, the Aging population and increment in the cardiovascular diseases are the Key driving variables for the development of the European bioabsorbable stents market. Positive results of surgeries with bioabsorbable stents and post-surgery reports additionally represent the advancement of the market. In any case, there are numerous administrative, innovative, safety-viability and furthermore cost-related issues that should be managed before achieving its maximum capacity.
KEY MARKET PLAYERS
Key market participants leading the Europe Bioabsorbable stents market include
- Elixir Medical Corporation
- Arterius Limited
- Amaranth Medical Inc.
- Abbott Laboratories
- Arterial Remodeling Technologies S.A.
- Biotronik
- Kyoto Medical Planning Co., Ltd.
- Reva Medical, Inc.
- Tepha, Inc.
- SMT
- Xenogenics Corporation
MARKET SEGMENTATION
This research report on the European bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.
By Material
- Polymer Stents
- Metallic Stents
By Absorption Rate
- Slow Absorption Rate Stents
- High Absorption Rate Stents
By Application
- Coronary Artery Disease
- Peripheral Artery Disease
By End User
- Hospitals
- Cardiac Centers
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe